CA2209496A1 - Nouveaux peptides, leur preparation et leur utilisation - Google Patents

Nouveaux peptides, leur preparation et leur utilisation

Info

Publication number
CA2209496A1
CA2209496A1 CA002209496A CA2209496A CA2209496A1 CA 2209496 A1 CA2209496 A1 CA 2209496A1 CA 002209496 A CA002209496 A CA 002209496A CA 2209496 A CA2209496 A CA 2209496A CA 2209496 A1 CA2209496 A1 CA 2209496A1
Authority
CA
Canada
Prior art keywords
gly
novel
aap10
ala
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002209496A
Other languages
English (en)
Inventor
Stefan Dhein
Tatjana Tudyka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2209496A1 publication Critical patent/CA2209496A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

L'invention concerne des composés de la formule (I) dans laquelle R, X, Y et Z ont la notation mentionnée dans la description, ainsi que leur préparation. Ces composés s'utilisent pour lutter contre des maladies.
CA002209496A 1995-01-14 1996-01-04 Nouveaux peptides, leur preparation et leur utilisation Abandoned CA2209496A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19500990.8 1995-01-14
DE19500990A DE19500990A1 (de) 1995-01-14 1995-01-14 Neues Peptid, seine Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
CA2209496A1 true CA2209496A1 (fr) 1996-07-18

Family

ID=7751510

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002209496A Abandoned CA2209496A1 (fr) 1995-01-14 1996-01-04 Nouveaux peptides, leur preparation et leur utilisation

Country Status (14)

Country Link
EP (1) EP0805818A1 (fr)
JP (1) JPH11511727A (fr)
KR (1) KR19980701397A (fr)
CN (1) CN1168142A (fr)
AU (1) AU4483696A (fr)
BR (1) BR9606756A (fr)
CA (1) CA2209496A1 (fr)
CZ (1) CZ204897A3 (fr)
DE (1) DE19500990A1 (fr)
FI (1) FI972965A (fr)
IL (1) IL116658A0 (fr)
NO (1) NO973230D0 (fr)
WO (1) WO1996021674A1 (fr)
ZA (1) ZA96239B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250397B2 (en) 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
ATE284896T1 (de) * 2000-02-23 2005-01-15 Zealand Pharma As Neue antiarrythmische peptide
US7585839B2 (en) 2000-02-23 2009-09-08 Zealand Pharma A/S Medical uses of intercellular communication facilitating compounds
DE60239126D1 (de) * 2001-02-22 2011-03-24 Zealand Pharma As Interzelluläre kommunikation erleichternden verbindungen und deren medizinischen verwendungen
MXPA03007537A (es) * 2001-02-22 2005-09-30 Zealand Pharma As Usos medicos nuevos de compuestos que facilitan la comunicacion intercelular.
EP1469875A1 (fr) * 2002-01-29 2004-10-27 Wyeth Compositions et procedes de modulation des demi-canaux de connexines
CN111303249B (zh) * 2020-01-02 2020-12-18 兰州大学 一种特异性检测病变胶原蛋白的探针、制备方法及应用

Also Published As

Publication number Publication date
FI972965A0 (fi) 1997-07-11
CN1168142A (zh) 1997-12-17
NO973230L (no) 1997-07-11
EP0805818A1 (fr) 1997-11-12
CZ204897A3 (en) 1997-12-17
MX9704796A (es) 1997-10-31
AU4483696A (en) 1996-07-31
WO1996021674A1 (fr) 1996-07-18
JPH11511727A (ja) 1999-10-12
KR19980701397A (ko) 1998-05-15
FI972965A (fi) 1997-07-11
BR9606756A (pt) 1998-01-06
DE19500990A1 (de) 1996-07-18
ZA96239B (en) 1997-07-14
NO973230D0 (no) 1997-07-11
IL116658A0 (en) 1996-05-14

Similar Documents

Publication Publication Date Title
US3853837A (en) Novel nonapeptide amide analogs of luteinizing hormone releasing factor
US4490291A (en) Nonapeptide amides
Dutta et al. Synthesis and biological activity of highly active. alpha.-aza analogs of luliberin
US4866160A (en) Therapeutic decapeptides
JPS5962556A (ja) 非天然アミノ酸
NO803883L (no) Cyclooctapeptider og farmasoeytiske preparater herav, samt fremgangsmaate til deres fremstilling og deres anvendelse
EP0458167B1 (fr) Conjugés acide gras-tensioactif pulmonaire
JPS61122297A (ja) 新規ハロ低級アルキルグアニジノ置換アミノ酸化合物およびその製法
US5073624A (en) Therapeutic decapeptides
HU189757B (en) Process for producing peptides of psichopharmaceutical activity
SK278507B6 (en) Biologically high active peptides, therapeutical preparation containing them and their use in therapy
CA2209496A1 (fr) Nouveaux peptides, leur preparation et leur utilisation
US3749703A (en) Asn15-bovine thyrocalcitonin
WAKIMASU et al. 4-Methoxy-2, 3, 6-trimethylbenzenesulfonyl (Mtr): a new amino and imidazole protecting group in peptide synthesis
CA1243307A (fr) Peptides influencant la fonction des gonades
US4512923A (en) Luteinizing and follicle stimulating hormones and process for the preparation thereof
MXPA97004796A (en) Novedous peptides, its preparation and
EP0225746A2 (fr) Décapeptides thérapeutiques
Manning et al. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine] oxytocin (hydroxy [4-thr] oxytocin), a peptide with strikingly high oxytocic potency, and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)] oxytocin (hydroxy-oxytocin)
US3801561A (en) Derivatives of salmon thyrocalcitonin
RO118297B1 (ro) Peptide biciclice si compozitie farmaceutica cu acestea
IE47547B1 (en) Psychopharmacological peptides suitable for therapeutic administration
DE60031133T2 (de) Verfahren zur darstellung von lh-rh-derivaten
US4261887A (en) Peptide compositions
EP0197798B1 (fr) Peptides

Legal Events

Date Code Title Description
FZDE Discontinued